130 related articles for article (PubMed ID: 18753229)
21. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
[TBL] [Abstract][Full Text] [Related]
22. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
[TBL] [Abstract][Full Text] [Related]
23. HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.
Brandenburg AH; de Waal L; Timmerman HH; Hoogerhout P; de Swart RL; Osterhaus AD
J Virol; 2000 Nov; 74(21):10240-4. PubMed ID: 11024156
[TBL] [Abstract][Full Text] [Related]
24. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
[TBL] [Abstract][Full Text] [Related]
25. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
[TBL] [Abstract][Full Text] [Related]
26. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
Anderson K; Stott EJ; Wertz GW
J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
28. Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses.
Yellen-Shaw AJ; Laughlin CE; Metrione RM; Eisenlohr LC
J Exp Med; 1997 Nov; 186(10):1655-62. PubMed ID: 9362526
[TBL] [Abstract][Full Text] [Related]
29. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing.
Ossevoort MA; Sijts AJ; van Veen KJ; Momburg F; Hämmerling GJ; Seelig A; Butcher GW; Howard JC; Kast WM; Melief CJ
Eur J Immunol; 1993 Dec; 23(12):3082-8. PubMed ID: 8258321
[TBL] [Abstract][Full Text] [Related]
30. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.
Gil-Torregrosa BC; Raúl Castaño A; Del Val M
J Exp Med; 1998 Sep; 188(6):1105-16. PubMed ID: 9743529
[TBL] [Abstract][Full Text] [Related]
31. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.
Khanna R; Burrows SR; Argaet V; Moss DJ
Int Immunol; 1994 Apr; 6(4):639-45. PubMed ID: 7517178
[TBL] [Abstract][Full Text] [Related]
32. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes.
Zhou X; Glas R; Momburg F; Hämmerling GJ; Jondal M; Ljunggren HG
Eur J Immunol; 1993 Aug; 23(8):1796-801. PubMed ID: 8393798
[TBL] [Abstract][Full Text] [Related]
33. The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent.
Tsujimura K; Obata Y; Iwase S; Matsudaira Y; Ozeki S; Takahashi T
Int Immunol; 2000 Sep; 12(9):1217-25. PubMed ID: 10967016
[TBL] [Abstract][Full Text] [Related]
34. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
[TBL] [Abstract][Full Text] [Related]
35. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
[TBL] [Abstract][Full Text] [Related]
36. The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.
Openshaw PJ; Anderson K; Wertz GW; Askonas BA
J Virol; 1990 Apr; 64(4):1683-9. PubMed ID: 2319650
[TBL] [Abstract][Full Text] [Related]
37. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
[TBL] [Abstract][Full Text] [Related]
38. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells.
Matsunaga Y; Fukuma D; Hirata S; Fukushima S; Haruta M; Ikeda T; Negishi I; Nishimura Y; Senju S
J Immunol; 2008 Nov; 181(9):6635-43. PubMed ID: 18941254
[TBL] [Abstract][Full Text] [Related]
39. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
Lobigs M; Müllbacher A
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
[TBL] [Abstract][Full Text] [Related]
40. TAP-independent presentation of CTL epitopes by Trojan antigens.
Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
